Recipient of federal assistance · SUNNYVALE, CA

PANORAMA RESEARCH INCORPORATED

PANORAMA RESEARCH INCORPORATED received $350K in federal grants and other assistance in FY2026, on 4 actions, −54% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $2.5M. Its largest awarding agency was National Institutes of Health ($350K).

Assistance · FY2026
$350K
New awards
1
Actions
4
Since FY2021
$2.5M
UEI
LYVHC3ARFRJ7
Location
SUNNYVALE, CA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 0FY2021
  2. 0FY2022
  3. 710.8KFY2023
  4. 709KFY2024
  5. 759KFY2025
  6. 350KFY2026

By type

  1. Grants$350K100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.395 · Cancer Treatment Research$387.2K100%
  2. 93.846 · Arthritis, Musculoskeletal and Skin Diseases Research-$37.2K0.0%

Awarding agencies

  1. National Institutes of Health$350K100%
    Department of Health and Human Services

Largest awards

  1. BOOSTING OVARIAN TUMORS' RESPONSES TO IMMUNOTHERAPY WITH UNIQUE SWITCHABLE SPLIT SUPERANTIGEN FUSED WITH ANTIBODIES TARGETING BINARY…$405K
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· May 17, 2024 – May 5, 2026· HT94252410411
  2. NOVEL MACROPHAGE REPOLARIZATION THERAPY FOR COLORECTAL CANCER - COLORECTAL CANCER RANKS THIRD IN CANCER DEATHS AMONG MEN AND FOURTH AMONG…$387.2K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 18, 2026 – Sep 18, 2026· R43CA310345
  3. NOVEL THERAPY FOR SARCOPENIA - NOVEL THERAPY FOR SARCOPENIA ABSTRACT SARCOPENIA, CHARACTERIZED BY LOSS OF SKELETAL MUSCLE MASS, QUALITY…$354K
    93.866 · Aging Research· National Institutes of Health· Project grant· Sep 18, 2025 – Aug 27, 2026· R43AG097164
  4. NOVEL THERAPY FOR ARTHROFIBROSIS - NOVEL THERAPY FOR ARTHROFIBROSIS ABSTRACT ARTHROFIBROSIS (AF) IS A COMMON RESULT OF JOINT SURGERIES. THE…$238.5K
    93.846 · Arthritis, Musculoskeletal and Skin Diseases Research· National Institutes of Health· Project grant· Sep 26, 2023 – Mar 13, 2026· R43AR082791

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.